- Home
- TRTX vs MPLT Comparison
TRTX vs MPLT Comparison
Compare TRTX & MPLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRTX
- MPLT
- Stock Information
- Founded
- TRTX 2014
- MPLT 2018
- Country
- TRTX United States
- MPLT United States
- Employees
- TRTX N/A
- MPLT N/A
- Industry
- TRTX Real Estate Investment Trusts
- MPLT Biotechnology: Pharmaceutical Preparations
- Sector
- TRTX Real Estate
- MPLT Health Care
- Exchange
- TRTX Nasdaq
- MPLT Nasdaq
- Market Cap
- TRTX 708.3M
- MPLT 700.6M
- IPO Year
- TRTX 2017
- MPLT 2025
- Fundamental
- Price
- TRTX $8.80
- MPLT $13.93
- Analyst Decision
- TRTX Buy
- MPLT Strong Buy
- Analyst Count
- TRTX 3
- MPLT 4
- Target Price
- TRTX $10.75
- MPLT $31.00
- AVG Volume (30 Days)
- TRTX 557.6K
- MPLT 415.1K
- Earning Date
- TRTX 10-28-2025
- MPLT 12-05-2025
- Dividend Yield
- TRTX 10.90%
- MPLT N/A
- EPS Growth
- TRTX N/A
- MPLT N/A
- EPS
- TRTX 0.65
- MPLT N/A
- Revenue
- TRTX $138,590,000.00
- MPLT N/A
- Revenue This Year
- TRTX N/A
- MPLT N/A
- Revenue Next Year
- TRTX $6.62
- MPLT N/A
- P/E Ratio
- TRTX $13.60
- MPLT N/A
- Revenue Growth
- TRTX 4.13
- MPLT N/A
- 52 Week Low
- TRTX $6.47
- MPLT $13.20
- 52 Week High
- TRTX $9.85
- MPLT $20.86
- Technical
- Relative Strength Index (RSI)
- TRTX 46.36
- MPLT N/A
- Support Level
- TRTX $8.68
- MPLT N/A
- Resistance Level
- TRTX $8.89
- MPLT N/A
- Average True Range (ATR)
- TRTX 0.16
- MPLT 0.00
- MACD
- TRTX -0.02
- MPLT 0.00
- Stochastic Oscillator
- TRTX 25.85
- MPLT 0.00
About TRTX TPG RE Finance Trust Inc.
TPG RE Finance Trust Inc is a commercial real estate finance company. It originates, acquires, and manages commercial mortgage loans and other commercial real estate-related debt instruments consisting of first mortgage loans and senior participation interests in first mortgage loans secured by institutional-quality properties in primary and select secondary markets in the United States. The company's objective is to provide attractive risk-adjusted returns to its stockholders over time through cash distributions and capital appreciation. It focuses on directly originating and selectively acquiring floating rate first mortgage loans that are secured by high quality commercial real estate properties undergoing some form of transition and value creation.
About MPLT MapLight Therapeutics Inc. Common Stock
MapLight Therapeutics Inc is a biopharmaceutical company. The company is focused on improving the lives of patients suffering from debilitating central nervous system, or CNS, disorders. The company is engaged in psychiatry and neuroscience research to address the lack of circuit-specific pharmacotherapies available for patients. The product candidates of the company include ML-007C-MA, ML-004, ML-021, ML-009, and other pipeline products.